p.Tyr365Cys change in factor VIII: Haemophilia A, but not as we know it

British Journal of Haematology

Volumn 154, Issue 5, 2011, Pages 618-625

  Bowyer, Annette E ^a   Goodeve, Anne ^a,d   Liesner, Ri ^b   Mumford, Andrew D ^c   Kitchen, Steve ^a   Makris, Mike ^a,d  

^a SHEFFIELD CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Assay discrepancy; Mild haemophilia A; P.Tyr365Cys

Indexed keywords

BLOOD CLOTTING FACTOR 8;

ADOLESCENT; ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; BLEEDING; BRUISING; CHILD; CLINICAL ARTICLE; COMORBIDITY; EPISTAXIS; FAMILY HISTORY; FEMALE; HEMOPHILIA A; HUMAN; MALE; MENORRHAGIA; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PARTIAL THROMBOPLASTIN TIME; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; UNITED KINGDOM; VON WILLEBRAND DISEASE;

BLOOD COAGULATION; FACTOR VIII; FAMILY; FEMALE; GREAT BRITAIN; HEMOPHILIA A; HEMORRHAGE; HUMANS; MALE; MUTATION, MISSENSE; PHENOTYPE;

EID: 80051588225     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08688.x     Document Type: Article

References (29)

1. Bowyer, A.E., Kitchen, S. & Makris, M. (2006a) Increasing incubation times in the chromogenic factor VIII:C assay influences assay discrepancy. Haemophilia, 12(Suppl. 2), 22, abstract 06PO172.
2. Bowyer, A.E., Kitchen, S., Van Veen, J., Goodeve, A.C. & Makris, M. (2006b) Factor VIII:C assay discrepancy may lead to failure to diagnose haemophilia A. Haemophilia, 12(Suppl. 2), 22, abstract 05PO84.
3. Cid, A.R., Calabuig, M., Cortina, V., Casaña, P., Haya, S., Moret, A., Cabrera, N. & Aznar, J.A. (2008) One-stage and chromogenic FVIII:C assay discrepancy in mild haemophilia A and the relationship with the mutation and bleeding phenotype. Haemophilia, 14, 1049-1054.
4. Cutler, J.A., Mitchell, M.J., Smith, M.P. & Savidge, G.F. (2002) The identification and classification of 41 novel mutations in the factor VIII gene (F8C). Human Mutation, 19, 274-278.
5. Duncan, E.M., Duncan, B.M., Tunbridge, L.J. & Lloyd, J.V. (1994) Familial discrepancy between the one-stage and two-stage factor VIII methods in a subgroup of patients with haemophilia A. British Journal of Haematology, 87, 846-848.
6. Eaton, D., Rodriguez, H. & Vehar, G.A. (1986) Proteolytic processing of human Factor VIII. Correlation of specific cleavages by thrombin, factor Xa and activated protein C with activation and inactivation of FVIII coagulant activity. Biochemistry, 25, 505-512.
7. Goodeve, A.C., Hinks, J.L., Nesbitt, I.M., Sampson, B., Burgess, C., Khair, K., Leisner, R., Kitchen, S., Peake, I.R. & Makris, M. (2001) Unusual discrepant factor VIII:C assays in haemophilia A patients with Tyr340Cys and Glu321Lys FVIII gene mutations. (Abstract). Thrombosis and Haemostasis, 86, 1(Suppl.), 1370.
8. Hathaway, W.E., Christian, M.J. & Jacobson, L.J. (1983) Variant mild haemophilia: discrepancy in one-stage & two-stage factor VIII assays. (Abstract). Thrombosis and Haemostasis, 50, 357.
9. Jayandharan, G., Shaji, R.V., Baidya, S., Nair, S.C., Chandy, M. & Srivastava, A. (2005) Identification of FVIII gene mutations in 101 patients with haemophilia A: mutation analysis by inversion screening and multiplex PCR and CSGE and molecular modelling of 10 novel missense substitutions. Haemophilia, 11, 481-491.
10. Keeling, D.M., Sukhu, K., Kemball-Cook, G., Waseem, N., Bagnall, R. & Lloyd, J.V. (1999) Diagnostic importance of the two-stage factor VIII:C assay demonstrated by a case of mild haemophilia associated with His1954Leu substitution in the A3 domain. British Journal of Haematology, 105, 1123-1126.
11. Keeney, S. (2011) Use of robotics in high-throughput DNA sequencing. Methods in Molecular Biology, 688, 227-237.
12. Lyall, H., Hill, M., Westby, J., Grimley, C. & Dolan, G. (2008) Tyr346→Cys mutation results in factor VIII:C assay discrepancy and a normal bleeding phenotype - is this mild haemophilia A? Haemophilia, 14, 78-80.
13. Mauser Bunschoten, E.P., van Howelingen, J.C., Sjamsoedin Visser, E.J., van Diijken, P.J., Kok, A.J. & Sixma, J.J. (1988) Bleeding symptoms in carriers of haemophilia A and B. Thrombosis and Haemostasis, 59, 349-352.
14. Mumford, A.D., Laffan, M., O'Donnell, J., McVey, J.H., Johnson, D.J.D., Manning, R.A. & Kemball-Cook, G. (2002) A Tyr346→Cys substitution in the interdomain acidic region a1 of FVIII in an individual with FVIII:C assay discrepancy. British Journal of Haematology, 118, 589-594.
15. Nosek-Cenkowska, B., Cheang, M.S., Pizzi, N.J., Israels, E.D. & Gerrard, J.M. (1991) Bleeding/bruising symptoms in children with and without bleeding disorders. Thrombosis and Haemostasis, 65, 237-241.
16. Over, J. (1984) Methodology of the one-stage assay of factor VIII (VIII:C). Scandinavian Journal of Haematology, 33(Suppl. 41), 13-24.
17. Parquet-Gernez, A., Mazurier, C. & Goudemand, M. (1988) Functional and immunological assays of FVIII in 133 haemophiliacs: characterisation of a subgroup of patients with mild haemophilia A and discrepancy in 1- and 2-stage assays. Thrombosis and Haemostasis, 59, 202-206.
18. Pittman, D.D., Wang, J.H. & Kaufman, R.J. (1992) Identification and functional importance of tyrosine sulfate residues within recombinant factor VIII. Biochemistry, 31, 3315-3325.
19. Pool, J.G. & Robinson, J. (1959) Assay of plasma antihaemophilic globulin. British Journal of Haematology, 5, 17-23.
20. Rodgers, S.E., Duncan, E.M., Barbulescu, D.M., Quinn, D.M. & Lloyd, J.V. (2007) In vitro kinetics of factor VIII activity in patients with mild haemophilia A and discrepancy between one-stage and two-stage factor VIII results. British Journal of Haematology, 136, 138-145.
21. Roelse, J.C., de Laaf, R.T.M., Mertens, K., van Mourik, J.A., Oldenburg, J. & Voorberg, J. (1999) Altered sensitivity towards factor IXa explains assay discrepancies in plasma of haemophilia A patients with Glu720→Lys substitution in factor VIII. Journal of Thrombosis and Haemostasis, 1, 2722, Suppl, abstract 5.
22. Saenko, E.L., Shima, M. & Sarafanov, A.G. (1999) Role of activation of the coagulation factor VIII in interaction with VWF, phospholipid and functioning within the Xase complex. Trends in Cardiovascular Medicine, 9, 185-192.
23. Schwaab, R., Oldenburg, J., Tuddenham, E.G., Brackmann, H.H. & Olek, K. (1993) Mutations in haemophilia A. British journal of haematology, 83, 450-458.
24. Silwer, J. (1973) Von Willebrand's disease in Sweden. Acta Paediatrica Scandinavica. Supplement, 238, 1-159.
25. Sramek, A., Eikenboom, J.C., Briet, E., Vandenbroucke, J.P. & Rosendaal, F.R. (1995) Usefulness of patient interview in bleeding disorders. Archives of Internal Medicine, 155, 1409-1415.
26. Tosetto, A., Rodeghiero, F., Castaman, G., Goodeve, A., Federici, A.B., Batlle, J., Meyer, D., Fressinaud, E., Mazurier, C., Goudemand, J., Eikenboom, J., Schneppenheim, R., Budde, U., Ingerslev, J., Vorlova, Z., Habart, D., Holmberg, L., Lethagen, S., Pasi, J., Hill, F. & Peake, I. (2006) A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD). Journal of Thrombosis and Haemostasis, 4, 766-777.
27. Trossaert, M., Regnault, V., Sigaud, M., Boisseua, P., Fressinaud, E. & Lecompte, T. (2008) Mild haemophilia A with factor VIII assay discrepancy: using thrombin generation assay to assess the bleeding phenotype. Journal of Thrombosis and Haemostasis, 6, 486-493.
28. Waseem, N.H., Bagnall, R., Green, P.M. & Gianelli, F. (1999) Start of UK confidential haemophilia database: analysis of 142 patients by solid phase fluorescent chemical cleavage of mismatch. Thrombosis and Haemostasis, 81, 900-905.
29. Williams, I.J., Abuzenadah, A., Winship, P.R., Preston, F.E., Dolan, G., Wright, J., Peake, I.R. & Goodeve, A.C. (1998) Precise carrier diagnosis in families with haemophilia A: use of conformation sensitive gel electrophoresis for mutation screening and polymorphism analysis. Thrombosis and Haemostasis, 79, 723-726.